Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
8.11
+0.44 (5.74%)
At close: Jun 26, 2026, 4:00 PM EDT
7.86
-0.25 (-3.08%)
After-hours: Jun 26, 2026, 6:29 PM EDT
Puma Biotechnology Employees
Puma Biotechnology had 179 employees as of December 31, 2025. The number of employees increased by 7 or 4.07% compared to the previous year.
Employees
179
Change (1Y)
7
Growth (1Y)
4.07%
Revenue / Employee
$1,269,151
Profits / Employee
$136,223
Market Cap
412.79M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| Enanta Pharmaceuticals | 120 |
| Adlai Nortye | 109 |
| Editas Medicine | 87 |
| Prelude Therapeutics | 79 |
| Century Therapeutics | 78 |
| Cybin | 50 |
| Eupraxia Pharmaceuticals | 49 |
PBYI News
- 25 days ago - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 7 weeks ago - Puma Biotechnology reports Q1 adjusted EPS (4c) vs (10c) last year - TheFly
- 7 weeks ago - Puma Biotechnology sees Q2 revenue $52M-$55M, one estimate $52M - TheFly
- 7 weeks ago - Puma Biotechnology raises FY26 revenue view to $222M-$229M from $214M-$221M - TheFly
- 7 weeks ago - Puma Biotechnology Earnings Call Transcript: Q1 2026 - Transcripts
- 7 weeks ago - Puma Biotechnology Earnings release: Q1 2026 - Filings
- 7 weeks ago - Puma Biotechnology Quarterly report: Q1 2026 - Filings
- 7 weeks ago - Puma Biotechnology Slides: Q1 2026 - Filings